Products & Technology
The Interventional Cardiology and Critical Care Products divisions both have track records of innovation in the development of next-generation medical technologies that make a difference in patients’ lives. A worldwide sales and marketing team and a network of distributors deliver our products to where they can help most.
Interventional Cardiology
The Interventional Cardiology division is focused on the development, manufacture and commercialization of drug-eluting stents, bare metal stents and angioplasty catheters.
BioMatrix™ is Biosensors’ unique abluminal biodegradable polymer DES. Its abluminal coating is absorbed after 6 to 9 months*. It combines the proven safety of a DES with an abluminal biodegradable polymer, the proven efficacy of BA9™ and an advanced stent design.
The latest generation bare metal stent, Gazelle™1, has been developed using the proprietary Quadrature Link™ design for enhanced flexibility. Available in a broad range of sizes, the proven stent platform provides the deliverability necessary for easy positioning.
Powerline™ offers excellent trackability and crossability for the treatment of complex lesions. The unique automated MultiPleat™ folding technology provides consistently low primary and secondary profiles to facilitate treatment of multi-vessel disease.
Critical Care Products
The Critical Care Products division develops and manufactures vascular catheters, pressure monitoring kits, arterial blood sampling kits and blood pressure transducers for use in open heart surgery and critical care areas of the hospital.
CAUTION: Prior to use, it is important to read the "Instructions for Use" supplied with these devices for indications, contraindications, suggested procedures, warnings, and precautions.
Biosensors’ interventional cardiology products, including BioMatrix™, Biolimus A9™, BA9™, Gazelle™, Quadrature Link™, S-Stent™, Powerline™ and MultiPleat™ are not available for sale in the United States and certain other countries.
* Data on file molecular weight <10kDa
